Stay updated on XIGDUO XR Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the XIGDUO XR Safety and Efficacy Clinical Trial page.

Latest updates to the XIGDUO XR Safety and Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe displayed ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check8 days agoChange DetectedAn NIH-wide banner announces transition updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence”.SummaryDifference1%

- Check15 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedThe site's footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check29 days agoChange DetectedThe study page displays a 403 Forbidden message with a Home link instead of study record content.SummaryDifference0.5%

- Check43 days agoChange DetectedThe study record page is blocked by a 403 Forbidden response, replacing the detailed study information with an error page. As a result, users cannot view the trial's title, conditions, locations, enrollment and other critical data that inform participation and understanding of the study.SummaryDifference16%

Stay in the know with updates to XIGDUO XR Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XIGDUO XR Safety and Efficacy Clinical Trial page.